Articles published by GB Sciences, Inc.





GB Sciences Files Provisional Patent Application to Protect Its Proprietary Drug Discovery Platform
April 07, 2021
From GB Sciences, Inc.
Via AccessWire
Tickers
GBLX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.